Striatal adenosine A2A and Cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of Cannabinoids

被引:189
作者
Carriba, Paulina
Ortiz, Oskar
Patkar, Kshitij
Justinova, Zuzana
Stroik, Jessica
Themann, Andrea
Mueller, Christa
Woods, Anima S.
Hope, Bruce T.
Ciruela, Francisco
Casado, Vicent
Canela, Enric I.
Lluis, Carme
Goldberg, Steven R.
Moratalla, Rosario
Franco, Rafael
Ferre, Sergi
机构
[1] NIDA, Preclin Pharmacol Sect, Dept Hlth & Human Serv, IRP,NIH, Baltimore, MD 21224 USA
[2] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain
[3] CSIC, Inst Cajal, E-28002 Madrid, Spain
[4] NIDA, Prote Lab, Dept Hlth & Human Serv, Intramural Res Program,NIH, Baltimore, MD USA
[5] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Dept Psychiat, Baltimore, MD 21201 USA
[6] Univ Bonn, Inst Pharmaceut, D-5300 Bonn, Germany
[7] NIDA, Neurobiol Relapse Sect, Dept Hlth & Human Serv, IRP,NIH, Baltimore, MD 21224 USA
关键词
adenosine A(2A) receptor; cannabinoid CB1 receptor; receptor heteromerization; striatum; cyclic AMP; motor activity;
D O I
10.1038/sj.npp.1301375
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The mechanism of action responsible for the motor depressant effects of cannabinoids, which operate through centrally expressed cannabinoid CB1 receptors, is still a matter of debate. In the present study, we report that CB1 and adenosine A(2A) receptors form heteromeric complexes in co-transfected HEK-293T cells and rat striatum, where they colocalize in fibrilar structures. In a human neuroblastoma cell line, CB1 receptor signaling was found to be completely dependent on A(2A) receptor activation. Accordingly, blockade of A(2A) receptors counteracted the motor depressant effects produced by the intrastriatal administration of a cannabinoid CB1 receptor agonist. These biochemical and behavioral findings demonstrate that the profound motor effects of cannabinoids depend on physical and functional interactions between striatal A(2A) and CB1 receptors.
引用
收藏
页码:2249 / 2259
页数:11
相关论文
共 43 条
[1]   Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons [J].
Agnati, LF ;
Ferré, S ;
Lluis, C ;
Franco, R ;
Fuxe, K .
PHARMACOLOGICAL REVIEWS, 2003, 55 (03) :509-550
[2]   How receptor mosaics decode transmitter signals.: Possible relevance of cooperativity [J].
Agnati, LF ;
Fuxe, K ;
Ferré, S .
TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (04) :188-193
[3]   Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons [J].
Andersson, M ;
Usiello, A ;
Borgkvist, A ;
Pozzi, L ;
Dominguez, C ;
Fienberg, AA ;
Svenningsson, P ;
Fredholm, BB ;
Borrelli, E ;
Greengard, P ;
Fisone, G .
JOURNAL OF NEUROSCIENCE, 2005, 25 (37) :8432-8438
[4]   CANNABINOID RECEPTORS AND MODULATION OF CYCLIC-AMP ACCUMULATION IN THE RAT-BRAIN [J].
BIDAUTRUSSELL, M ;
DEVANE, WA ;
HOWLETT, AC .
JOURNAL OF NEUROCHEMISTRY, 1990, 55 (01) :21-26
[5]   The effective stagnant thermal conductivity of porous media with periodic structures [J].
Cheng, P ;
Hsu, CT .
JOURNAL OF POROUS MEDIA, 1999, 2 (01) :19-38
[6]   Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers [J].
Ciruela, F ;
Casadó, V ;
Rodrigues, RJ ;
Luján, R ;
Burgueño, J ;
Canals, M ;
Borycz, J ;
Rebola, N ;
Goldberg, SR ;
Mallol, J ;
Cortés, A ;
Canela, EI ;
López-Giménez, JF ;
Milligan, G ;
Lluis, C ;
Cunha, RA ;
Ferré, S ;
Franco, R .
JOURNAL OF NEUROSCIENCE, 2006, 26 (07) :2080-2087
[7]   ZM241385 is an antagonist of the facilitatory responses produced by the A(2A) adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus [J].
Cunha, RA ;
Constantino, MD ;
Ribeiro, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (07) :1279-1284
[8]   Δ9-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB1 receptor antagonist/inverse agonist SR 141716A [J].
Darmani, NA .
NEUROPSYCHOPHARMACOLOGY, 2001, 24 (02) :198-203
[9]   Cannabinoid signalling [J].
Demuth, DG ;
Molleman, A .
LIFE SCIENCES, 2006, 78 (06) :549-563
[10]  
FELDER CC, 1995, MOL PHARMACOL, V48, P443